PAO-YU CHENMu, Jung-JungJung-JungMuLin, Hsiu-YingHsiu-YingLinKO-JEN LIPING-ING LEEPO-REN HSUEH2022-02-102022-02-102011-020163-4453https://scholars.lib.ntu.edu.tw/handle/123456789/593993enVARIANT[SDGs]SDG2[SDGs]SDG3ampicillin; C reactive protein; ceftriaxone; chloramphenicol; ciprofloxacin; cotrimoxazole; methylprednisolone sodium succinate; prednisolone; RNA 16S; tetracycline; acute kidney failure; adult; antibiotic sensitivity; bacterial gene; bacterium culture; case report; cholera; ctx A gene; ctx B gene; dehydration; diarrhea; feces culture; fluid therapy; follow up; gene sequence; human; hypergammaglobulinemia; immunocompromised patient; letter; male; minimum inhibitory concentration; nonhuman; nucleotide sequence; occult blood; Sjoegren syndrome; Taiwan; Vibrio cholerae; Base Sequence; Cholera; Ciprofloxacin; Disease Notification; Foodborne Diseases; Humans; Immunocompromised Host; Male; Middle Aged; RNA, Ribosomal, 16S; Sjogren's Syndrome; Taiwan; Vibrio cholerae O1Vibrio cholerae O1 infection in Taiwanletter10.1016/j.jinf.2010.12.007211871122-s2.0-79551606393WOS:000286981200010https://scholars.lib.ntu.edu.tw/handle/123456789/480059